The Company Has Made New Progress on Hesperidin

Recently, the company and the School of Traditional Chinese Medicine at Beijing University of Chinese Medicine conducted collaborative scientific research on Neohesperidin Dihydrochalcone and its synthetic precursor. The study focused on investigating its pharmacological properties including antioxidant, antibacterial, anti-inflammatory effects, as well as liver and kidney protection, hypoglycemic and lipid-lowering effects. Furthermore, it explored its potential in improving gastrointestinal function, cardiovascular health, nerve damage prevention, reproductive system protection, among other areas. These novel findings were jointly published in the Journal of Food Industry Science and Technology.

The Neohesperidin Dihydrochalcone is a non-toxic sweetener characterized by its high sweetness and low calorie content. It possesses various functionalities including sweetening, flavor enhancement, bitter taste masking, flavor modification, as well as pharmacological activities such as antioxidant, anti-inflammatory, and lipid-lowering effects. Consequently, it exhibits significant potential for development in the fields of food and medicine. This paper provides a comprehensive review of the pharmacological actions and mechanisms of Neohesperidin Dihydrochalcone while summarizing the progress made in researching its synthetic precursors. The aim is to offer valuable insights for further utilization of Neohesperidin Dihydrochalcone and the development of high-value products.

The company has consistently prioritized investments in science and technology, maintaining strong research and development collaborations with prestigious institutions such as South China University of Technology, Beijing University of Chinese Medicine, and Tsinghua University. To date, the company has filed 35 patents centered around Nutian and NHDC, including 9 granted invention patents and 10 utility model patents. The company has been recognized as a national high-tech enterprise, a specialized and distinguished enterprise in Shandong Province, a “gazelle” enterprise in Shandong Province, an exemplary Qilu model enterprise for the high-quality development of the feed industry in Shandong Province.

Additionally, it has received the third prize for outstanding scientific and technological products in Shandong Province. Furthermore, it is designated as Dongying City’s Multi-functional High-Sweetener Key Laboratory, One Enterprise One Technology Research and Development Center,” Intellectual Property Demonstration Enterprise,” key cultivation enterprises for high-growth SMEs in Dongying City,and also serves as a demonstration enterprise promoting the “Four Modernizations” under Dongying City’s “Four New” initiative.

Recently, the company and the School of Traditional Chinese Medicine at Beijing University of Chinese Medicine conducted collaborative scientific research on Neohesperidin Dihydrochalcone and its synthetic precursor. The study focused on investigating its pharmacological properties including antioxidant, antibacterial, anti-inflammatory effects, as well as liver and kidney protection, hypoglycemic and lipid-lowering effects. Furthermore, it explored its potential in improving gastrointestinal function, cardiovascular health, nerve damage prevention, reproductive system protection, among other areas. These novel findings were jointly published in the Journal of Food Industry Science and Technology.

The Neohesperidin Dihydrochalcone is a non-toxic sweetener characterized by its high sweetness and low calorie content. It possesses various functionalities including sweetening, flavor enhancement, bitter taste masking, flavor modification, as well as pharmacological activities such as antioxidant, anti-inflammatory, and lipid-lowering effects. Consequently, it exhibits significant potential for development in the fields of food and medicine. This paper provides a comprehensive review of the pharmacological actions and mechanisms of Neohesperidin Dihydrochalcone while summarizing the progress made in researching its synthetic precursors. The aim is to offer valuable insights for further utilization of Neohesperidin Dihydrochalcone and the development of high-value products.

The company has consistently prioritized investments in science and technology, maintaining strong research and development collaborations with prestigious institutions such as South China University of Technology, Beijing University of Chinese Medicine, and Tsinghua University. To date, the company has filed 35 patents centered around Nutian and NHDC, including 9 granted invention patents and 10 utility model patents. The company has been recognized as a national high-tech enterprise, a specialized and distinguished enterprise in Shandong Province, a “gazelle” enterprise in Shandong Province, an exemplary Qilu model enterprise for the high-quality development of the feed industry in Shandong Province.

Additionally, it has received the third prize for outstanding scientific and technological products in Shandong Province. Furthermore, it is designated as Dongying City’s Multi-functional High-Sweetener Key Laboratory, One Enterprise One Technology Research and Development Center,” Intellectual Property Demonstration Enterprise,” key cultivation enterprises for high-growth SMEs in Dongying City,and also serves as a demonstration enterprise promoting the “Four Modernizations” under Dongying City’s “Four New” initiative.